News Focus
News Focus
Followers 68
Posts 5584
Boards Moderated 0
Alias Born 01/13/2012

Re: legaltips post# 103027

Wednesday, 03/15/2017 11:03:15 AM

Wednesday, March 15, 2017 11:03:15 AM

Post# of 353361
I will take JNJ or GSK stock 8 days a week! No question, BIEL is a potential target of interest for every player in the pain space. USPTO patents, miniaturized pain management device, FDA USA OTC cleared, with FDA clearance certifying it is both efficacious and safe? Combining IP and clearance - only such device on earth!

Only a question now of when someone blinks. If I am BIEL's CEO, I can say nothing, by law! But to think it is not of interest to others is an absurd lack of sophistication, since every pharma executive in the world wants to protect and grow market share. This is about nothing else. And, when it is appropriate for us to know, it will happen, not if, but when . . . .



















Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y